Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

FDA Approves Acculasers Carpal Tunnel Technology
Aug 2002
SAN DIEGO, Aug. 6 -- Acculaser Inc. has received approval from the Food and Drug Administration to market the company's Acculaser Pro Cold Laser for use in the non-surgical treatment and management of pain for carpal tunnel syndrome.

"We are very excited to be able to offer this innovative non-surgical approach to people suffering from carpal tunnel pain," said Jackson Streeter CEO of Acculaser.

Acculaser is also pursuing FDA clearance for treatment of tendonitis, and is conducting animal research in the area of bone regeneration in collaboration with the Medical College of Wisconsin.

News & Featureslasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.